TAHL CINDY (CIK 1655472) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-05). Recent activity: Sell FATE (38,800 shares), Sell FATE (25,590 shares), Buy FATE (122,220 shares), Buy FATE (44,444 shares), Buy FATE (100,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-05 | FATE THERAPEUTICS INC (FATE) | Chief Legal and Compliance Officer | Sell | 38,800 | $95,405 |
| 2026-05-21 | FATE THERAPEUTICS INC (FATE) | Chief Legal and Compliance Officer | Sell | 25,590 | $48,109 |
| 2026-05-07 | FATE THERAPEUTICS INC (FATE) | Chief Legal and Compliance Officer | Buy | 122,220 | $161,330 |
| 2026-05-07 | FATE THERAPEUTICS INC (FATE) | Chief Legal and Compliance Officer | Buy | 44,444 | $46,666 |
| 2026-01-16 | FATE THERAPEUTICS INC (FATE) | Chief Legal and Compliance Officer | Buy | 100,000 | $0 |
| 2026-01-12 | FATE THERAPEUTICS INC (FATE) | Chief Legal and Compliance Officer | Sell | 10,589 | $11,224 |
| 2025-08-05 | FATE THERAPEUTICS INC (FATE) | Chief Legal and Compliance Officer | Sell | 9,037 | $9,579 |
来源：SEC Form 4 申报文件 · 截至 2026-08-05